← All diseases Heart and blood vessels

Cardiac amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (41)Meta-analysis (6)Treatment guideline (1)Phase 3 study (19)Systematic review (12)Randomized Controlled Trial (3)Clinical trial (374)Review article (176)Early study (phase 1 or 2) (7)Case report (199)Laboratory or animal study (2)Commentary or Editorial (86) Studies currently recruiting participants only (37)

Filter

Publications and studies (1416)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist. (2020/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis. (2020/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Efficacy of Chemotherapies and Stem Cell Transplantation for Systemic AL Amyloidosis: A Network Meta-Analysis. (2020/01/28) ♡
• S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genetics of Cerebral Small Vessel Disease. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Catalytic antibody (catabody) platform for age-associated amyloid disease: From Heisenberg's uncertainty principle to the verge of medical interventions. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Temporal artery involvement in AL amyloidosis: an important differential diagnosis for giant cell arteritis. A case report and literature review. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fundamentals of Light Chain Cardiac Amyloidosis: A Focused Review. (2020/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy (2020-12-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Amyloidosis : Diagnostic Using Red Flag Signals (2020-11-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Patient-Reported Outcome Measures in Wild-Type and Variant Cardiac Transthyretin Amyloidosis (2020-09-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries. (2020-08-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis (2020-07-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Bidimensional Shear Wave Elastography) in Patients With Transthyretin Amyloidosis (2020-07-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Carnitine for the Treatment of Atherosclerosis. (2020-06-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Lipid-Rich Plaque Study (2020-05-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Morpho-functional Cardiac Modifications in Treated Mutated Transthyretin Cardiac Amyloidosis (2020-05-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Amyloidosis in Heart Failure (PREVAMIC) (2020-03-05) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance. (2019/12/26) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. (2019/12/25) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Advantages and Emerging Problems of Novel Treatments for Transthyretin Cardiac Amyloidosis. (2019/12/25) ♡
• Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis. (2019/12/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in the treatment of chronic heart failure. (2019/12/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy. (2019/12/17) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Call for New Therapies in Heart Failure: How Cardiology Can Learn From Oncology. (2019/12/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lactobacillus Endocarditis-Associated Glomerulonephritis Complicated by anti-Coagulant Nephropathy and Renal Amyloidosis. (2019/12/17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry. (2019/12/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloid and the Heart. (2019/12/03) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A simple case of heart failure? Isolated cardiac amyloidosis. (2019/12/02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease. (2019/12/01) ♡
• Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction. (2019/12/01) ♡
• Commentary on Some Recent Theses Relevant to Combating Aging: December 2019. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloidosis in Heart Failure. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. HFpEF: an enigma being slowly but surely unravelled. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of cardiac amyloidosis presenting with chronic pericardial effusion and conduction block. (2019/12/01) ♡
• Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. (2019/12/01) ♡
• [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis]. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ventricular Assist Device Support in End-Stage Heart Failure From Cardiac Amyloidosis. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant. (2019/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cardiac Amyloidosis Associated with Apolipoprotein A-IV Deposition Diagnosed by Mass Spectrometry-Based Proteomic Analysis. (2019/11/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week. (2019/11/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multi-modality imaging in transthyretin amyloid cardiomyopathy. (2019/11/26) ♡
• Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy. (2019/11/12) ♡
• Atrial Fibrillation in the Elderly: The Role of Sub-Clinical Isolated Cardiac Amyloidosis. (2019/11/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Native aortic valve endocarditis with Morganella morganii in a patient with multiple myeloma and valvular amyloidosis: a case report. (2019/11/10) ♡
• CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice. (2019/11/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. AL Amyloidosis: Unfolding a Complex Disease. (2019/11/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.